LIPID PROFILE AND GLUCOSE TOLERANCE DURING INTERVENTION WITH ROSIGLITAZONE, A PPAR-GAMMA AGONIST, IN BRAZILIAN OBESE SUBJECTS

Autor:	M.L.G. Rodrigues, Stenio Fernando Pimentel Duarte, V. Genelhu-Abreu, D. C. Valenca, M. M.G. Pimentel, Emilio Antonio Francischetti, S.G. Barroso, Antonio Felipe Sanjuliani
Rok vydání:	2004
Předmět:	medicine.medical_specialty medicine.diagnostic_test Physiology business.industry PPAR agonist Endocrinology Internal medicine Intervention (counseling) Internal Medicine medicine Obese subjects Cardiology and Cardiovascular Medicine Lipid profile Rosiglitazone business medicine.drug
Zdroj:	Journal of Hypertension. 22:S85
ISSN:	0263-6352
DOI:	10.1097/00004872-200406002-00290
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::41295d0b47a0ad0d4f8a71532e8281a9 https://doi.org/10.1097/00004872-200406002-00290 Zobrazit plný text záznamu